The aim of the work was to conduct a retrospective analysis
of the clinical data of patients with pneumonia caused by the SARS-CoV-2
virus, and to determine via mathematical methods the significance
of some physiological and biochemical indices as predictive markers
of an unfavorable outcome of the disease. A random cohort of patients
with COVID-19 pneumonia numbered 209 people. Mathematical analysis
addressed the physiological characteristics of patients recorded
at the time of hospital admission, as well as blood coagulation
parameters and those reflecting the development of an inflammatory
reaction. The analyzed parameters were categorized relative to the
reference ranges of physiologically normal values. Correlation analysis
was carried out using categorical data on the disease outcome. The
algorithms for calculating statistical characteristics, as well
as results visualization, were programmed in Python. When comparing
patient groups, the significance of differences between the determined
parameters was assessed using the Pearson’s χ
2
test
with Yates’ correction. The study showed that the age over 50 and
male sex can be considered risk factors for patients with COVID-19
pneumonia (
p
< 0.05). The
disease outcome was found to be significantly affected by cardiovascular
pathologies (
p
< 0.01) and
to a lesser extent by diabetes mellitus (
p
<
0.10). There were revealed maximal correlation coefficients between
the oxygen saturation level (–0.43), as well as the breathing rate
(0.43), and a fatal outcome of the disease. For patients over 50
years of age, oxygen saturation below 80% at the time of hospital
admission turned out to be a marker of mortality. It was shown that
D-dimer blood levels above 625 ng/mL in patients over 80 years of
age correlated with mortal outcomes. No correlation was found between the
C-reactive protein (CRP) level and the disease outcome. The effect
of corticosteroids on the disease outcome was analyzed in patients
with different CRP levels. It was found that, while using corticosteroids,
the mortality rate in patients with CRP ≤ 12.5 mg/L is 2.7 times
higher than in those with CRP > 12.5 mg/L (
p
<
0.01). Thus, the use of adequate mathematical methods made it possible
to define more precisely some mortality-associated physiological
and biochemical indices in patients with COVID-19 pneumonia.